Skip to search formSkip to main contentSkip to account menu

infliximab 100 MG Injection [Remicade]

Known as: INFLIXIMAB, LICENSE HOLDER UNSPECIFIED 100 mg in 10 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [REMICADE], Remicade 100 MG Injection, Remicade 100 MG per 10 ML Injection 
National Institutes of Health

Related topics

Related topics

6 relations
InjectionPolysorbate 80RemicadeSucrose

Broader (1)

infliximab Injection [Remicade]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The UK Competition Authority closes its investigation into an allegedly abusive discount scheme in the pharmaceutical sector (Remicade)
The CMA Remicade decision: discount schemes and abuse of dominance – effects matter!* Summary On 14 March 2019, the UK… 
2018
2018
Acknowledgement to Referees
2018
2018
INFLIXIMABE: ANTICORPO MONOCLONAL NA TERAPÊUTICA DA ARTRITE REUMATOIDE
A artrite reumatoide e uma patologia autoimune inflamatoria sistemica cronica de origem desconhecida, que acomete a membrana… 
Review
2018
Review
2018
Acknowledgement to Referees
Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review. McKinnon, R.A., Cook, M., Liauw, W. et al… 
2015
2015
Efficacité du traitement par anakinra (anti-IL1) dans le psoriasis
2015
2015
FRI0109 Methotrexate Reduced TNF Bioactivity by Anti-Infliximab Antibody Prevention in Rheumatoid Arthritis Patients Treated with Infliximab
Background Since biologic therapy development, rheumatoid arthritis (RA) prognosis improves dramatically. Tumor necrosis factor… 
2008
2008
Case Study: Immunogenicity of Anti-TNF Antibodies
Anti-tumor necrosis factor (TNF) therapy has become an important alternative in the management of several chronic… 
Review
2006
Review
2006
Infliximab in the treatment of psoriasis
Psoriasis is one of the most common chronic inflammatory diseases with a prevalence of 2–3%. Traditional treatment options in… 
2006
2006
TNF-α receptor polymorphism association with Infliximab therapy outcome in a Swedish Crohn ’ s disease population
Background: Crohn’s disease (CD) is an inflammatory bowel disease (IBD) with a strong component of TNF-α (tumor necrosis factor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)